key: cord-1044899-48rcv58j authors: Fei, Fei; Smith, John A.; Cao, Liyun title: Clinical laboratory characteristics in patients with suspected COVID‐19: One single‐institution experience date: 2020-10-05 journal: J Med Virol DOI: 10.1002/jmv.26527 sha: e0d19120d0b1ab5ad0a33b3f8a70f331390d640d doc_id: 1044899 cord_uid: 48rcv58j OBJECTIVES: Since December 2019, the outbreak of coronavirus disease 2019 (COVID‐19) has become a worldwide pandemic. The aim of the study is to investigate the demographic, clinical, and laboratory characteristics in suspected COVID‐19 patients in our institution. METHODS: In this retrospective study, we investigated suspected COVID‐19 patients admitted to the University of Alabama at Birmingham with a request for an interleukin‐6 send‐out test, from March 28 to June 27, 2020. Patients' demographic, clinical, and laboratory characteristics were collected by chart review. RESULTS: Fifty patients suspected with COVID‐19 were included in our study, of whom 24 patients were positive with severe acute respiratory syndrome coronavirus‐2 infection and 26 were negative. During the observation period, 30 patients were discharged, 17 died during hospitalization, and three remained in hospital. Compared to non‐COVID‐19 patients, COVID‐19 patients had older age, more comorbidities, and elevated levels of inflammation markers such as erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), serum ferritin, and lactate dehydrogenase (LDH). However, there was no significant difference in laboratory data between survivors and nonsurvivors in COVID‐19 patients in our study. CONCLUSION: This study indicated that potential risk factors of older age, multiple comorbidities, and high levels of ESR, CRP, serum ferritin, and LDH could help the clinician to identify potential COVID‐19 patients. However, this data needs to be further validated in a larger population. Descriptive analyses were performed for categorical variables and compared by Fisher′s exact test or χ 2 test. Continuous variables were expressed as the mean ± SD and compared by independent sample t-test. p Value less than .05 was considered statistically sig- In the next step, we investigated the factors associated with SARS-CoV-2 infection by comparing the patients' laboratory data at admission between COVID-19 patients and non-COVID-19 patients. As shown in Table 2 , the levels of ESR, CRP, serum ferritin, and LDH were significantly higher in COVID-19 patients compared to non-COVID-19 patients (p < .05). However, no significant differences were identified in other laboratory data including BUN, creatinine, Alk phos, ALT, AST, procalcitonin, hs-cTnI, CK, white blood cell (WBC), red blood cell, hemoglobin, platelet, neutrophils counts, lymphocytes counts, monocytes counts, IL-6, PT, PTT, INR, fibrinogen, and D-dimer between COVID-19 patients and non-COVID-19 patients. A total of 24 COVID-19 patients were followed until discharge (two patients remained hospitalization), and the longest follow-up time was 57 days. The demographic characteristics and laboratory data of patients were compared between survivors and nonsurvivors ( Our retrospective study identified several risk factors for patients who were hospitalized due to suspected SARS-CoV-2 infection. In particular, older age and comorbidities were associated with a higher prevalence of SARS-CoV-2 infection. Additionally, elevated levels of CRP, ESR, serum ferritin, and LDH were more commonly seen in COVID-19 patients. Previous studies indicated that patients confirmed with SARS-CoV-2 infection had an older age compared to suspected patients. 4, 12 Moreover, increased age was associated with death in patients with SARS-CoV-2 infection. 5 Opal et al. 13 found that the age-dependent defects in the functions of T-cells and B-cells cloud cause the deficiency in inhibiting viral replication combined with age-related excess production of type 2 cytokine, leading to a poor outcome. Consistent with previous studies, we observed that COVID-19 patients were older than non-COVID-19 patients. In general, old patients with more coexisting illness, for example, diabetes, hypertension, CAD, and COPD were more likely to infect SARS-CoV-2 and develop severe symptoms. 2, 4, [14] [15] [16] We also noticed that SARS-CoV-2 infected patients had more comorbidities than patients without SARS-CoV-2 infection. Henry et al. 6 performed a meta-analysis involving 21 studies showed that inflammatory biomarkers including ESR, CRP, serum ferritin, IL-6, procalcitonin, and IL-2R were significantly elevated in patients with both severe and fetal COVID-19. Previous studies have shown that the main cause of rapid disease progression is the excessive inflammatory responses due to cytokine release syndrome. 9, 17, 18 Multiple studies have shown that higher concentrations of IL-6 were associated with the severity of COVID-19. 4, 9, 19 Furthermore, IL-6 blocking treatment (e.g., tocilizumab) may prevent the there is no statistically significant difference between the two groups (Table 2 ). In addition, there is no statistically significant difference between the survivors and nonsurvivors of COVID-19 patients (Table 4) . These discrepancies could be due to the small sample size. Hematologic markers (WBC count, neutrophil count, lymphocyte count, and platelet count), biochemical markers (BUN, creatinine, and CK), and coagulation markers (D-dimer and PTT) were also reported to be correlated with severity and mortality of COVID-19 patients. [4] [5] [6] [7] 25 However, we did not find any association of these data in COVID-19 patients which could be due to a limited sample size. Our study has some limitations. First, our institution is a large tertiary referral hospital, thereby many severe patients were transferred from outside hospitals without effective treatment contributing to poor clinical outcomes in some patients. Second, our study included a high percentage of black or African American patients who are known to have high rates of SARS-CoV-2 infection and mortality due to the high prevalence of cardiometabolic comorbidities and socioeconomic vulnerabilities. Last but not the least, we only had 24 COVID-19 patients in our study, so our findings may be limited due to the small sample size. In summary, our study indicated that COVID-19 patients were associated with high levels of ESR, CRP, LDH, and serum ferritin. The inflammatory lab panel could be used as an indicator to evaluate COVID-19 infection, however, this needs to be further validated in a larger population. The authors declare that there are no conflict of interests. Fei Fei was involved in the data collection and manuscript preparation. John A. Smith was involved in the revision of the manuscript. Liyun Cao was involved in the preparation and revision of the manuscript. The data that support the findings of this study are available on reasonable request from the corresponding author. Liyun Cao http://orcid.org/0000-0003-2795-1407 Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention Clinical characteristics of coronavirus disease 2019 in China Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients The laboratory's role in combating COVID-19 Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis Dysregulation of immune response in patients with COVID-19 in Wuhan, China The epidemiologic and clinical features of suspected and confirmed cases of imported 2019 novel coronavirus pneumonia in north Shanghai The immunopathogenesis of sepsis in elderly patients Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-Infected pneumonia in Wuhan, China Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19 Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a casecontrol study High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study COVID-19: consider cytokine storm syndromes and immunosuppression Interleukin-6 as a potential biomarker of COVID-19 progression Effective treatment of severe COVID-19 patients with tocilizumab Tocilizumab treatment in COVID-19: a single center experience Tocilizumab: a new opportunity in the possible therapeutic arsenal against COVID-19 Why tocilizumab could be an effective treatment for severe COVID-19? Cardiac injury is associated with severe outcome and death in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies How to cite this article: Fei F, Smith JA, Cao L. Clinical laboratory characteristics in patients with suspected COVID-19: one single-institution experience